Specialty Pharmacy

The Pharmacy Times® Pharmacy Technician Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to specialty pharmacists.

Latest News

The FDA approved meloxicam and rizatriptan (Symbravo; Axsome Therapeutics Inc) for the acute treatment of migraine, either with or without aura | Image Credit: goodluz | stock.adobe.com
FDA Approves Symbravo for Acute Treatment of Migraine With or Without Aura

January 30th 2025

Meloxicam and rizatriptan reduces migraine pain and help patients return to normal functioning with efficacy through 24 to 48 hours after a single dose for some patients.

The FDA previously granted fast track, orphan drug, and rare pediatric disease designations for apitegromab. | Image Credit: Rochu_2008 | stock.adobe.com
Scholar Rock Submits FDA Application for Apitegromab to Improve Motor Function in Spinal Muscular Atrophy

January 30th 2025

Coronavirus molecules.
Common Osteoporosis Treatments May Offer Protection Against COVID-19

January 29th 2025

Chronic kidney disease diagnosis papers -- Image credit: Zerbor | stock.adobe.com
Iron Deficiency Is Prevalent in Patients With Non-Anemia, Non-Dialysis-Dependent-CKD

January 29th 2025

Progress pride flag -- Image credit: Marcela Ruty Romero | stock.adobe.com
Understanding Gender-Affirmative Care Beyond Women’s Health

January 29th 2025

More News